Abstract LB-55: The European Cancer Patient Coalition speaks with a single voice for all cancer patients

Abstract

Abstract Established in 2003, The European Cancer Patient Coalition is the voice of the European cancer patient community, uniquely representing the interests of all cancer patient groups from the major to the rarer cancers. ECPC is an independent, non-profit “umbrella” organization based in Brussels close to the European institutions, governed by an elected Board of seven members most of whom must be cancer patients, survivors or carers. ECPC maintains close links with EU institutions (Commission, Parliament, Council, and European Medicines Agency). ECPC monitors political development at EU level, identifies those which could impact the field of oncology, informs its member societies and supports European health issues. Priority Areas- • Influence EU policy that has an impact on the prevention, detection and treatment of cancer. • Reach out to national level to support ECPC members in their capacity building efforts on the national level • Build strategic partnerships with key cancer stakeholders to create mutual benefit One of ECPC's key priorities is to make cancer a priority for action on the European health policy agenda. With its policy activities, ECPC aims to effect change in legislative or regulatory policies to help optimize cancer prevention, detection, treatment and care throughout Europe. The policies also need to ensure that gaps within and between Member States are identified and eradicated, and that best practice is shared. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-55. doi:1538-7445.AM2012-LB-55